台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    24.35
  • 漲跌
    ▲0.30
  • 漲幅
    +1.25%
  • 成交量
    241
  • 產業
    上櫃 生技醫療類股
  • 150人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/15 ~ 2024/04/29     後一日»

券商獲利排行 - 2024/04/15 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.63%31.4031.4206206024.224.2024.4
  2.30%18.1018.13333023.823.8024.4
  1.10%11.9-0.312.33745824242424.4
  0.50%9.78.31.3-30508024.324.224.424.4
  0.75%7.27.3-0.1-1394024.224.124.324.4
  1.42%6.606.6-1901924.7024.724.4
  0.42%6.206.26161024.224.2024.4
  0.45%5.7-0.15.842521024.224.224.224.4
  0.84%5.705.72828024.124.1024.4
  0.97%5.40.84.62023324.224.124.424.4
  0.77%5.205.22828024.224.2024.4
  2.02%4.82.12.8410523.923.824.224.4
  1.82%4.804.81111023.923.9024.4
  1.16%4.44.9-0.5-2141623.923.824.124.4
  0.90%4.42.81.6-9112024.424.324.524.4
  0.98%4.304.31818024.124.1024.4
  0.63%4042526024.224.224.124.4
  0.87%3.8-0.84.514184242423.824.4
  1.36%3.603.61011024242424.4
  1.46%3.503.59100242424.324.4
  1.58%3.403.49902424024.4
  1.25%3031010024.124.1024.4
  1.35%2.902.9990242424.424.4
  0.46%2.93.4-0.5-9172624.224.124.324.4
  1.62%2.802.8-70724.8024.824.4
  2.29%2.82.800552423.824.324.4
  1.06%2.60.42.1710324.12424.224.4
  1.17%2.61.21.459424.224.124.424.4
  1.04%2.52.500101024.12424.324.4
  1.01%2.51.90.5310724.324.224.524.4
  0.35%2.402.42828024.324.3024.4
  0.40%2.42.20.20252424.224.124.224.4
  0.68%2.302.31414024.224.2024.4
  2.42%2.302.344023.823.8024.4
  1.88%2.302.355023.923.9024.4
  1.53%2.22.10.206524.424.224.624.4
  1.08%2.102.188024.124.1024.4
  0.81%202-1001024.6024.624.4
  0.65%1.90.71.2712524.224.224.324.4
  1.98%1.90.41.53412423.924.324.4
  1.04%1.801.877024.124.1024.4
  1.78%1.70.21.534123.923.82424.4
  1.72%1.701.744023.923.9024.4
  0.44%1.601.61515024.224.2024.4
  1.11%1.601.666024.124.1024.4
  1.25%1.501.555024.124.1024.4
  2.10%1.501.533023.923.9024.4
  1.25%1.51.5005524.123.924.224.4
  0.37%1.501.51616024.324.3024.4
  0.13%1.401.44243124.324.324.324.4

券商虧損排行 - 2024/04/15 ~ 2024/04/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.29%-19.12.2-21.3-15911026924.224.224.224.4
  -0.33%-120.8-12.7-144414824.324.124.324.4
  -1.39%-11.70-11.7-350352402424.4
  -3.00%-10.70-10.7-1501523.6023.624.4
  -0.83%-10.1-1.6-8.5-36145024.124.224.124.4
  -0.64%-8.50-8.5-5505524.2024.224.4
  -1.34%-8.40-8.4-260262402424.4
  -2.40%-6.80-6.8-1101223.82423.824.4
  -1.19%-6.3-0.5-5.8-2112224.124.624.124.4
  -0.41%-6.2-6.50.31636124.224.224.124.4
  -1.82%-6.10-6.1-1401423.924.423.924.4
  -0.89%-5.8-0.9-4.9-1972724.124.224.124.4
  -0.83%-5.80.3-6.1-2622924.12424.124.4
  -0.59%-5.4-5.408382924.324.424.224.4
  -0.95%-4.90-4.92121024.624.6024.4
  -0.56%-4.8-0.9-3.93335224.424.52424.4
  -1.81%-4.80-4.8-1101123.9023.924.4
  -0.89%-4.30.2-4.5-1822024.12424.124.4
  -1.39%-4.1-1.5-2.5-1021224.224.924.124.4
  -0.23%-40-4-7017124.324.324.324.4
  -1.67%-40-4-901024242424.4
  -2.10%-40-4-80823.9023.924.4
  -0.70%-3.9-1.4-2.5-13102324.224.324.224.4
  -1.14%-3.8-0.4-3.5-1031424.124.12424.4
  -0.71%-3.60-3.6-2102124.2024.224.4
  -0.73%-3.6-1.6-2-1552024.324.524.224.4
  -1.62%-3.5-0.3-3.2-8192424.32424.4
  -1.25%-30-3-1001024.1024.124.4
  -0.56%-2.90-2.9-2102124.2024.224.4
  -0.56%-2.80-2.8-2002124.224.224.224.4
  -1.06%-2.80-2.8-1101124.1024.124.4
  -0.88%-2.8-0.5-2.3-1031324.224.324.124.4
  -1.00%-2.70-2.7-1101124.1024.124.4
  -1.84%-2.6-1.6-1-1462424.323.924.4
  -0.98%-2.60-2.6-1101124.1024.124.4
  -0.81%-2.50.4-2.9-1211324.123.724.124.4
  -0.60%-2.50-2.51717024.524.5024.4
  -0.50%-2.4-2.90.510201024.224.32424.4
  -2.30%-2.2-1-1.2-22423.924.223.724.4
  -0.51%-2.1-2.104171324.324.324.224.4
  -1.06%-20-2-80824.1024.124.4
  -1.06%-20-2-80824.1024.124.4
  -0.83%-20-2-1001024.2024.224.4
  -1.01%-2-1.2-0.8-35824.224.324.124.4
  -0.37%-1.80-1.8-2002024.3024.324.4
  -0.83%-1.8-0.3-1.5-63924.124.224.124.4
  -1.88%-1.80-1.8-40423.9023.924.4
  -1.25%-1.50-1.5-50524.1024.124.4
  -1.25%-1.50-1.5-50524.1024.124.4
  -1.00%-1.50-1.5-60624.1024.124.4
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章